BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2005

View Archived Issues

Schering AG plans additional phase III Crohn's disease trial for sargramostim

Read More

Phase IIa trials begin for melanoma vaccine CYT-004-MelQbG10

Read More

ABC2 and Genentech collaborate to study Avastin for GBM

Read More

Ranbaxy completes proof-of-concept for antimalarial RBx-11160

Read More

Orapred ODT filing accepted for review

Read More

Ark receives license to manufacture commercial supplies of gene-based medicine

Read More

Intercell aligns with CDC for development of Pneumococcus vaccine

Read More

New phase I study for Amplimexon plus docetaxel in cancer patients

Read More

Phase II study of Xanafide plus ara-C for secondary AML

Read More

Alinea announces Series A financing

Read More

Cardium Therapeutics and Aries Ventures to merge

Read More

Idera seeks to amend HYB-2055 phase II protocol

Read More

Viprovex studied as potential treatment for anthrax infection

Read More

Etomoxir reemerges as a potential antipsoriatic agent

Read More

Living Cell Technologies requests pre-IND meeting for NeurotrophinCell product

Read More

MedImmune and Avidia combine strengths to develop anticancer products

Read More

Repositioning study indicates utility of EVT-201 for insomnia

Read More

Approvable letter for Sparlon for ADHD

Read More

Levemir approved for use in children

Read More

New data on the immunomodulatory effects of FTY-720

Read More

SP-600125 evokes suppression of primary T-cell inhibition in vitro

Read More

Therapeutic benefits reported for transdermal lisuride in RLS

Read More

New data supports the use of pramipexole in restless legs syndrome

Read More

Low toxicity, beneficial activity seen with BLP25 liposome vaccine in lung cancer

Read More

Tesaglitazar improves lipids, glucose metabolism in insulin-resistant subjects

Read More

Recent patents cover new agents for inflammatory disorders

Read More

New therapeutics for cancer disclosed in recent patent literature

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing